Cocrystal Pharma, Inc. (Nasdaq: COCP) announced that the last subject has been dosed in its Phase 1b norovirus human challenge ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE